Use our newly updated directory of stakeholders in the global CBD sector to find the most relevant organisations in key markets, with full Web, email, phone and address details. Available exclusively to CBD-Intel subscribers, this once-yearly updated database is a consoldated, user-friendly Excel file. Note that this file is password protected; please enter the password: […]

US cannabis firm Trulieve has bought Harvest Health and Recreation in a $2.1bn deal that aims to create the US’s most profitable cannabis company in what is being billed as the largest US cannabis transaction to date

Pain is a familiar part of everybody’s life, yet it remains a remarkably hard subject to study. It therefore is unsurprising that studies have come to differing conclusions on the use of cannabis and cannabinoids for pain relief

CBD pouches are currently most likely to fall under a general consumer regime, considering the existing EU legal framework. This report discusses the various ways in which such products could be regulated at EU level

Two US firms, Greenlane and KushCo, have merged in a deal that aims to create a major manufacturer and distributor of cannabis accessories in the US

Significant cannabis reform is inevitably coming to congress, no matter whether the Biden administration considers it a priority, and giants in experienced lobbying industries are preparing their agents

This report offers an in-depth look at the current regulatory framework for hemp, CBD and cannabis in the UK, including its medical and recreational cannabis regime

When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration

Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships

This report identifies the top online retailers selling into the CBD market in the UK and provides insights into the prevalence of brands and product types being offered

With federal elections due in September, Germany’s Free Democratic Party (FDP) has called on the government to draft a law permitting the controlled distribution of cannabis for adult use

South Africa releases the National Cannabis Master Plan, which will not only boost and uplift the southern Africa cannabis industry, but will set a regional precedent for the growth of a legal cannabis market in the area

Poland’s Parliamentary Team for the Legalisation of Marijuana has submitted a package of three draft bills to the speaker of parliament’s lower chamber, following a public consultation on the proposals

CBD will become legal for the first time in Slovakia on 1st May 2021. This report offers a detailed overview of the regulatory framework in the country for hemp, CBD and medical and recreational cannabis

CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications

The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released

CBD-Intel’s newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.

Use the tabs at the top of the map to select a specific regulatory field and click on an individual country to bring up much more detail in the panel below, including links to legislation and CBD-Intel’s coverage of that market.

The key below the map indicates the level of regulation for the selected country and regulatory field based on our in-house analysis.

Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however

Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria

Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on the island

Welcome to the CBD-Intel US enacted law regulatory tracker, updated each month. Within this interactive map gain insight into the enacted bills for 22 US states, with more state coverage coming very soon.

Welcome to the new and improved CBD-Intel US state law regulatory tracker, updated every month and exclusively focused on state law. This interactive map allows you to search for states, zoom in and out from the map, view more than one regulatory area at a time, pan the map and select multiple states to compare regulations.

A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US

While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics

Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic for financial institutions too

The US Customs and Border Protection (CBP) agency is wrongly seizing legal hemp and hemp-related shipments – such as farm equipment that it claims constitutes drug paraphernalia – according to two recently-filed lawsuits

Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September

Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country

Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature

As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person

It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop

Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics?

Cultivation of hemp with less than 0.2% THC is legal in Denmark. This report provides an overview of the country’s regulatory framework for CBD, hemp and cannabis

Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA

States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest

This report offers an overview of the current regulatory framework in place for hemp, CBD and cannabis in Sweden

This report provides an overview of the regulatory regime for CBD, hemp and cannabis in Taiwan

Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes

The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework

The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost?

Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of intoxication

This report addresses the changes to the product offering and brand landscape for CBD products in Italy between the third and fourth quarters of 2020